19200 Participants Needed

Integrated Dementia Care Interventions for Alzheimer's and Dementia

SS
DH
Overseen ByDiana Hernandez, BS
Age: 65+
Sex: Any
Trial Phase: Academic
Sponsor: NYU Langone Health
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications.

What data supports the effectiveness of the treatment Community Paramedic-led Transitions Intervention (CPTI), Emergency Care Redesign (ECR), Nurse-led Telephonic Care (NLTC) for Alzheimer's and Dementia?

Research shows that integrated care strategies, which include community-based interventions and coordinated care, have been effective in reducing hospital transfers and improving care for people with dementia. These strategies emphasize care coordination, teamwork, and personalized care, which are key components of the treatments being studied.12345

Is the Integrated Dementia Care Intervention safe for humans?

The available research suggests that interventions like the Community Paramedic-led Transitions Intervention (CPTI) and similar programs are designed to improve care transitions and reduce hospital admissions for people with dementia, which can enhance safety by preventing adverse outcomes associated with hospital stays. However, specific safety data for these interventions in humans is not detailed in the provided studies.15678

How is the Community Paramedic-led Transitions Intervention (CPTI) treatment for dementia unique?

The Community Paramedic-led Transitions Intervention (CPTI) is unique because it focuses on reducing unnecessary hospital admissions by providing care in the community, which is particularly beneficial for dementia patients who often experience poor outcomes in hospital settings. This approach involves paramedics making more person-focused decisions and utilizing community resources to manage care effectively at home.12349

What is the purpose of this trial?

The purpose of this study is to improve the care of persons living with dementia (PLWD) and their informal care partners by addressing emergency and post-emergency care through different combinations of three PLWD-care partner dyad focused interventions. The primary aims are to use coaching to help connect PLWD and their care partners with community support and services to improve transitional care, quality of care, care satisfaction and reduce future ED visits and hospitalizations.

Research Team

JC

Joshua Chodosh, MD

Principal Investigator

NYU Langone Health

Eligibility Criteria

This trial is for people aged 66 and older diagnosed with Alzheimer's or related dementias, who have had multiple health visits for these conditions. Their care partners must be adults over 18. It's not open to patients under the age of 66.

Inclusion Criteria

I have been diagnosed with Alzheimer's or related dementia at least twice, once in an outpatient setting.
I am 66 years old or older.

Exclusion Criteria

I am younger than 66 years old.

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Intervention

Participants receive different combinations of interventions focused on improving emergency and post-emergency care for persons living with dementia and their care partners.

12 weeks

Follow-up

Participants are monitored for safety and effectiveness after interventions, focusing on transitional care, quality of care, and reduction in future ED visits and hospitalizations.

12 weeks

Treatment Details

Interventions

  • Community Paramedic-led Transitions Intervention (CPTI)
  • Emergency Care Redesign (ECR)
  • Nurse-led Telephonic Care (NLTC)
Trial Overview The study tests three interventions: Nurse-led Telephonic Care (NLTC), Emergency Care Redesign (ECR), and Community Paramedic-led Transitions Intervention (CPTI) to improve post-emergency care for dementia patients.
Participant Groups
8Treatment groups
Experimental Treatment
Active Control
Group I: Two interventions: NLTC and CPTIExperimental Treatment2 Interventions
Group II: Two interventions: ECR and CPTIExperimental Treatment2 Interventions
Group III: Two intervention: ECR and NLTCExperimental Treatment2 Interventions
Group IV: Single intervention: Nurse-led Telephonic Care (NLTC)Experimental Treatment1 Intervention
Group V: Single intervention: Emergency Care Redesign (ECR)Experimental Treatment1 Intervention
Group VI: Single intervention: Community Paramedic-led Transitions Intervention (CPTI)Experimental Treatment1 Intervention
Group VII: All interventions: ECR, NLTC, and CPTIExperimental Treatment3 Interventions
Group VIII: No interventionActive Control1 Intervention
No intervention, serving as a usual care control group

Find a Clinic Near You

Who Is Running the Clinical Trial?

NYU Langone Health

Lead Sponsor

Trials
1,431
Recruited
838,000+

National Institute on Aging (NIA)

Collaborator

Trials
1,841
Recruited
28,150,000+

Findings from Research

The ADMIT Me tool was developed to improve safe transitions of care for individuals with Alzheimer's and dementia, based on feedback from focus groups involving caregivers, emergency department nurses, and first responders.
Participants in the focus groups unanimously agreed that the ADMIT Me tool would enhance safety during care transitions by promoting clear communication and collaboration among healthcare providers, ultimately leading to more patient-centered care.
Enhancing the ADMIT Me Tool for Care Transitions for Individuals With Alzheimer's Disease.Moore, JR., Sullivan, MM.[2018]
Community care coordination has shown promise in reducing the rate of nursing home admissions for older people with dementia, with a significant risk ratio of 0.66 based on data from 303 participants across two studies.
Other non-pharmacological interventions, such as psychoeducation and multifactorial approaches, did not demonstrate a significant effect on preventing hospital or nursing home admissions, suggesting that not all interventions are equally effective.
Non-pharmacological interventions to prevent hospital or nursing home admissions among community-dwelling older people with dementia: A systematic review and meta-analysis.Lee, DA., Tirlea, L., Haines, TP.[2021]
The DementiaNet program, which lasted for 2 years, significantly improved collaboration among 35 primary care networks and enhanced the quality of dementia care, with measurable increases in both areas during the program.
These improvements in collaboration and care quality were sustained even after the program ended, suggesting that DementiaNet successfully facilitated a lasting transition to integrated primary dementia care.
DementiaNet facilitates a sustainable transition toward integrated primary dementia care: A long-term evaluation.Oostra, DL., Nieuwboer, MS., Melis, RJF., et al.[2023]

References

Home or hospital for people with dementia and one or more other multimorbidities: What is the potential to reduce avoidable emergency admissions? The HOMEWARD Project Protocol. [2021]
Integrated care for adults with dementia and other cognitive disorders. [2019]
Key components in models of community-based interventions coordinating care in dementia: a mixed studies systematic review protocol. [2021]
Efficacy of a geriatrics team intervention for residents in dementia-specific assisted living facilities: effect on unanticipated transitions. [2008]
Impact of health service interventions on acute hospital use in community-dwelling persons with dementia: A systematic literature review and meta-analysis. [2020]
Enhancing the ADMIT Me Tool for Care Transitions for Individuals With Alzheimer's Disease. [2018]
Non-pharmacological interventions to prevent hospital or nursing home admissions among community-dwelling older people with dementia: A systematic review and meta-analysis. [2021]
Evaluation of a safe medication strategy intervention for people with dementia with an unplanned admission: Results from the Safe Medication Strategy Dementia Study. [2021]
DementiaNet facilitates a sustainable transition toward integrated primary dementia care: A long-term evaluation. [2023]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security